ARE ANTIBIOTICS BECOMING A ‘NON SUSTAINABLE’ DRUG SUPPLY?

With increasing resistance to existing antibiotics and little incentive for pharmaceutical companies to invest in new ones, developing countries face a serious challenge combating killer diseases such as tuberculosis and typhoid fever. SciDev.net has put together a package of news, comment and analysis on this topic, which links closely to the STEPS Centre’s Rethinking Regulation…

CHINESE EXPORTS: DANGER, REGULATION AND SECURITY

By GERRY BLOOM, STEPS Centre member Over the past few months there have been a number of stories in the international media about dangerous exports from China. On the one hand, this reflects a recognition that China needs to establish regulatory systems to ensure the good performance of its burgeoning market economy. The failures of…

Cotton farming in Hubei province

By ADRIAN ELY, STEPS Centre member In Hubei Province, I was fortunate to be able to visit two villages and, with the help of an interpreter, talk to several local people about their perspectives on local agri-environmental conditions and the prospects for rural development. Whilst expressing their appreciation of some of the government’s policies, it…

RISK IN INDIA: NEW PHARMACEUTICALS & PATENT LAW

By ESHA SHAH, STEPS Centre member Controversy over the extent to which private pharmaceutical interests can creep into the debates around public good has arisen recently here in India. A technical expert committee constituted by the government of India to look into the patent laws with respect to new pharmaceuticals and micro-organisms recently withdrew its…

RISK, UNCERTAINTY AND EMERGING TECHNOLOGIES IN INDIA

By ESHA SHAH, STEPS Centre member Our time is marked by a rapid technological change and associated anxieties about public and private risks, a significant part of which remain uncertain and unpredictable and yet could have enormous potential to influence our present and future. The STEPS Centre is looking into how different institutions and groups…